— Know what they know.
Not Investment Advice
Also trades as: JSPR (NASDAQ) · $vol 1M

JSPRW NASDAQ

Jasper Therapeutics, Inc.
1W: -96.0% 1M: -98.3% 3M: -98.5% YTD: -99.7% 1Y: -99.9% 3Y: -99.7%
$0.00
-0.00 (-84.62%)
 
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 39 · $3251 mcap · 14M float · 0.136% daily turnover · Short 57% of daily vol

Supply Chain Overview

10 relationships
10
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2021-05-06
Earliest Filing
2021-09-29
Latest Filing
investor: 6 acquirer: 2 target: 2

Counterparties (Filed by JSPRW)

10 relationships

Companies named in JSPRW's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Amplitude Healthcare Acquisition Corporation AMPL acquirer Predecessor company that merged with Old Jasper to form New Jasper. 2021-09-29 View
Ample Merger Sub, Inc. — acquirer Wholly-owned subsidiary of AMHC that merged with Old Jasper. 2021-09-29 View
Jasper Therapeutics, Inc. JSPRW target Target company (Old Jasper) that merged with AMHC to form the combined company. 2021-09-29 View
Amgen Inc. AMGN investor PIPE Investor subscribing for Class A Common Stock of AMHC. 2021-09-29 View
Amplitude Healthcare Holdings LLC AMPL investor Sponsor entity subscribing for Class A Common Stock of AMHC. 2021-09-29 View
Citadel Multi-Strategy Equities Master Fund LTD. — investor PIPE Investor subscribing for Class A Common Stock of AMHC. 2021-09-29 View
Qiming U.S. Healthcare Fund II, L.P. — investor PIPE Investor subscribing for Class A Common Stock of AMHC. 2021-09-29 View
Roche Finance Ltd — investor PIPE Investor subscribing for Class A Common Stock of AMHC. 2021-09-29 View
Jasper Therapeutics, Inc. JSPRW target Target company in the business combination agreement to be merged with Merger Sub. 2021-05-06 View
Amplitude Healthcare Holdings LLC AMPL investor Sponsor entity entering into a support agreement to vote for the business combination. 2021-05-06 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-10-01 Exhibits View
2026-09-28 Officer/Director Change View
2026-08-26 Material Agreement Agreement View
2026-08-14 Earnings Release; Exhibits View
2026-08-03 Shareholder Vote View
2026-07-31 Other Events View
2026-07-17 Material Agreement; Acquisition/Disposition; Unregistered Equity Sales; Officer/Director Change; Byl Agreement Acquisition View
2026-07-16 Regulation FD; Exhibits View
2026-06-09 Delisting Notice View
2026-06-01 Regulation FD; Exhibits View
2026-05-21 Officer/Director Change; Exhibits View
2026-03-30 Earnings Release; Exhibits View
2026-01-08 Other Events; Financial Statements and Exhibits View
2026-01-07 Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh View
2025-12-02 Other Events; Financial Statements and Exhibits View
2025-11-10 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-09-19 Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits Agreement View
2025-08-13 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-07-09 Costs Associated with Exit or Disposal Activities; Departure/Election of Directors; Appointment of O View
2025-07-07 Other Events; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms